Javier Fernández Díaz
Laminar Pharmaceuticals
CSO Assistant
Bachelor's in Biology. Master in Applied Biotechnology and PhD in Biomedical and Evolutionary Biotechnology. Currently CSO Assistant at Laminar Pharma, a Spanish Biotech dedicated to the rational design and development of drugs. Currently in Phase 3 clinical trials with LAM561 in patients with glioblastoma, the most common and aggressive brain tumor. Expecting marketing approval in 2024